Anna Pieczonka

599 total citations
31 papers, 202 citations indexed

About

Anna Pieczonka is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anna Pieczonka has authored 31 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 14 papers in Public Health, Environmental and Occupational Health and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anna Pieczonka's work include Acute Lymphoblastic Leukemia research (14 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Anna Pieczonka is often cited by papers focused on Acute Lymphoblastic Leukemia research (14 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Anna Pieczonka collaborates with scholars based in Poland, Italy and Sweden. Anna Pieczonka's co-authors include Jacek Wachowiak, Jolanta Goździk, Jerzy Kowalczyk, Krzysztof Kałwak, Olga Zając‐Spychała, Jan Styczyński, Katarzyna Knapczyk‐Stwora, Agnieszka Rak, Mariusz Wysocki and Małgorzata Grzesiak and has published in prestigious journals such as Blood, BMC Cancer and Frontiers in Oncology.

In The Last Decade

Anna Pieczonka

29 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Pieczonka Poland 9 107 60 45 45 32 31 202
Agnieszka Zaucha‐Prażmo Poland 10 94 0.9× 65 1.1× 57 1.3× 68 1.5× 25 0.8× 50 253
Caitrin Fretham United States 6 107 1.0× 37 0.6× 30 0.7× 28 0.6× 49 1.5× 9 176
Andrzej Kołtan Poland 9 51 0.5× 84 1.4× 60 1.3× 40 0.9× 39 1.2× 34 180
Parameswaran Anoop India 9 67 0.6× 31 0.5× 30 0.7× 47 1.0× 25 0.8× 48 222
Bénedicte Bruno France 10 132 1.2× 53 0.9× 73 1.6× 91 2.0× 54 1.7× 24 280
Lauren Pommert United States 8 102 1.0× 56 0.9× 33 0.7× 57 1.3× 65 2.0× 30 228
Gaurav Kharya India 10 109 1.0× 61 1.0× 49 1.1× 32 0.7× 34 1.1× 31 266
Yael Klionsky United States 8 42 0.4× 40 0.7× 42 0.9× 30 0.7× 55 1.7× 18 196
A. Birgitta Versluijs Netherlands 8 197 1.8× 54 0.9× 29 0.6× 60 1.3× 96 3.0× 10 257
Lydia Foeken United States 6 115 1.1× 39 0.7× 20 0.4× 32 0.7× 35 1.1× 12 165

Countries citing papers authored by Anna Pieczonka

Since Specialization
Citations

This map shows the geographic impact of Anna Pieczonka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Pieczonka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Pieczonka more than expected).

Fields of papers citing papers by Anna Pieczonka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Pieczonka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Pieczonka. The network helps show where Anna Pieczonka may publish in the future.

Co-authorship network of co-authors of Anna Pieczonka

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Pieczonka. A scholar is included among the top collaborators of Anna Pieczonka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Pieczonka. Anna Pieczonka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wachowiak, Jacek, K Czyźewski, Katarzyna Drabko, et al.. (2024). Wskazania do transplantacji komórek krwiotwórczych u dzieci i młodzieży w 2024 roku — rekomendacje Polskiej Pediatrycznej Grupy ds. Transplantacji Komórek Krwiotwórczych. Homo Politicus (Academy of Humanities and Economics in Lodz). 4(1-2). 1–17.
2.
Ussowicz, Marek, Aleksandra Wieczorek, Anna Pieczonka, et al.. (2021). Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma—A National Retrospective Study. Frontiers in Oncology. 11. 647361–647361. 8 indexed citations
3.
Popko, Katarzyna, Yenan T. Bryceson, Bianca Tesi, et al.. (2021). Molecular Genetics Diversity of Primary Hemophagocytic Lymphohistiocytosis among Polish Pediatric Patients. Archivum Immunologiae et Therapiae Experimentalis. 69(1). 31–31. 8 indexed citations
4.
5.
Bilska, Katarzyna, Olga Gryniewicz–Kwiatkowska, Joanna Stefanowicz, et al.. (2020). Clinical characteristics and outcome of pediatric patients diagnosed with Langerhans cell histiocytosis in pediatric hematology and oncology centers in Poland. BMC Cancer. 20(1). 874–874. 3 indexed citations
6.
Dalle, Jean‐Hugues, Adriana Balduzzi, Peter Bader, et al.. (2020). The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG. Bone Marrow Transplantation. 56(1). 257–266. 9 indexed citations
7.
Zaucha‐Prażmo, Agnieszka, Joanna Zawitkowska, Monika Lejman, et al.. (2019). Infection profile in children and adolescents with bone marrow failures treated with allogeneic hematopoietic stem cell transplantation. Pediatric Transplantation. 23(8). e13592–e13592. 2 indexed citations
8.
9.
Zając‐Spychała, Olga, et al.. (2019). Long-Term Recipient Health-Related Quality of Life and Donor-Recipient Relationship following Sibling Pediatric Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(2). 401–406. 6 indexed citations
10.
Dalle, Jean‐Hugues, Adriana Balduzzi, Peter Bader, et al.. (2018). Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes. Biology of Blood and Marrow Transplantation. 24(9). 1848–1855. 20 indexed citations
11.
12.
Goździk, Jolanta, Anna Pieczonka, Robert Dębski, et al.. (2014). Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients. Bone Marrow Transplantation. 50(1). 51–55. 11 indexed citations
13.
Wójcik, Rafał, et al.. (2014). Budget Impact Analysis of Aflibercept in yhe Treatment of Metastatic Colorectal Cancer (MCRC) in Poland. Value in Health. 17(7). A621–A621. 1 indexed citations
14.
Pieczonka, Anna, et al.. (2013). Cost-Effectiveness of Plerixafor (PXF) for Stem Cell Mobilization in Lymphoma (NHL/HL) and Multiple Myeloma (MM) Patients in Poland. Value in Health. 16(7). A384–A385. 1 indexed citations
15.
Szpecht, Dawid, Ewa Gorczyńska, Krzysztof Kałwak, et al.. (2012). Matched Sibling Versus Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Children with Severe Acquired Aplastic Anemia: Experience of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation. Archivum Immunologiae et Therapiae Experimentalis. 60(3). 225–233. 20 indexed citations
16.
Styczyński, Jan, Krzysztof Kałwak, Marek Ussowicz, et al.. (2012). Przeszczepianie krwi pępowinowej w polskich ośrodkach pediatrycznych: raport Polskiej Pediatrycznej Grupy ds. Transplantacji Komórek Krwiotwórczych. Acta Haematologica Polonica. 43(3). 265–270. 1 indexed citations
17.
Derwich, Katarzyna, Łukasz Sędek, Claus Meyer, et al.. (2009). Infant acute bilineal leukemia. Leukemia Research. 33(7). 1005–1008. 6 indexed citations
18.
19.
20.
Wachowiak, Jacek, Jerzy Kowalczyk, Alicja Chybicka, et al.. (2001). Pediatric hematopoietic stem cell transplantation in Poland – development and current status. Reports of Practical Oncology & Radiotherapy. 6. S15–S15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnieszka Zaucha‐Prażmo Breakdown of academic impact, for papers by Caitrin Fretham Breakdown of academic impact, for papers by Andrzej Kołtan Breakdown of academic impact, for papers by Parameswaran Anoop Breakdown of academic impact, for papers by Bénedicte Bruno Breakdown of academic impact, for papers by Lauren Pommert Breakdown of academic impact, for papers by Gaurav Kharya Breakdown of academic impact, for papers by Yael Klionsky Breakdown of academic impact, for papers by A. Birgitta Versluijs Breakdown of academic impact, for papers by Lydia Foeken
Rankless by CCL
2026